Fluoxetine 40 MG Oral Capsule — RxCUI 313989
RxNorm drug concept · Semantic clinical drug
RxCUI 313989
Semantic clinical drug · SCD
● Current RxNorm concept 98 FDA products
280 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI313989
Official nameFluoxetine 40 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfluoxetine 40 MG (as fluoxetine HCl 44.8 MG) Oral Capsule
FDA products mapped98
Package NDCs mapped280
Reported Medicaid activity (SDUD)4,191,968 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fluoxetine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Most people don't feel a noticeable difference right away — that's completely normal. It typically takes several weeks to start feeling the full benefit, and some people need a few...
- How long does it take for fluoxetine to actually start working?
- It's really important not to stop on your own, even if you feel great. Stopping suddenly can cause discontinuation symptoms, and your condition may come back. The good news is that...
- Can I stop taking fluoxetine if I start feeling better?
🕸️ Concept Web — How Fluoxetine 40 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fluoxetine 40 MG Oral Capsule
RxCUI 313989 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Fluoxetine
4493IN
-
Fluoxetine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Prozac
58827BN
-
Prozac
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fluoxetine Oral Capsule
372231SCDF -
Fluoxetine Oral Product
1160836SCDG -
Fluoxetine Pill
1160837SCDG -
Fluoxetine Oral Capsule [Prozac]
93904SBDF -
Prozac Oral Product
1182486SBDG -
Prozac Pill
1182487SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Fluoxetine Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fluoxetine 40 MG
330341SCDC -
Fluoxetine 40 MG Oral Capsule [Prozac]
261287SBD -
Fluoxetine 40 MG [Prozac]
574512SBDC
-
Fluoxetine 40 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fluoxetine 40 MG
SCDC · 330341 -
Fluoxetine Oral Capsule
SCDF · 372231 -
Fluoxetine Oral Product
SCDG · 1160836 -
Fluoxetine Pill
SCDG · 1160837
Brand-Name Concepts
-
Fluoxetine 40 MG Oral Capsule [Prozac]
SBD · 261287 -
Fluoxetine 40 MG [Prozac]
SBDC · 574512 -
Fluoxetine Oral Capsule [Prozac]
SBDF · 93904 -
Prozac Oral Product
SBDG · 1182486 -
Prozac Pill
SBDG · 1182487 -
Prozac
BN · 58827
📦 FDA Products & Package NDCs
98 products · 280 package NDCs
280 package NDCs map to RxCUI 313989 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 72241-0007-05 | 100 CAPSULE in 1 BOTTLE (72241-007-05) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0007-10 | 500 CAPSULE in 1 BOTTLE (72241-007-10) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0007-11 | 1000 CAPSULE in 1 BOTTLE (72241-007-11) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0007-22 | 30 CAPSULE in 1 BOTTLE (72241-007-22) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0008-05 | 100 CAPSULE in 1 BOTTLE (72241-008-05) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0008-10 | 500 CAPSULE in 1 BOTTLE (72241-008-10) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0008-11 | 1000 CAPSULE in 1 BOTTLE (72241-008-11) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0008-22 | 30 CAPSULE in 1 BOTTLE (72241-008-22) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0009-05 | 100 CAPSULE in 1 BOTTLE (72241-009-05) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0009-10 | 500 CAPSULE in 1 BOTTLE (72241-009-10) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72241-0009-22 | 30 CAPSULE in 1 BOTTLE (72241-009-22) | Fluoxetine | Modavar Pharmaceuticals LLC | 2021-09-08 |
| 72603-0488-01 | 100 CAPSULE in 1 BOTTLE (72603-488-01) | Fluoxetine | NorthStar Rx LLC | 2025-09-01 |
| 72603-0488-02 | 1000 CAPSULE in 1 BOTTLE (72603-488-02) | Fluoxetine | NorthStar Rx LLC | 2025-09-01 |
| 72603-0489-01 | 100 CAPSULE in 1 BOTTLE (72603-489-01) | Fluoxetine | NorthStar Rx LLC | 2025-09-01 |
| 72603-0489-02 | 1000 CAPSULE in 1 BOTTLE (72603-489-02) | Fluoxetine | NorthStar Rx LLC | 2025-09-01 |
| 72603-0490-01 | 100 CAPSULE in 1 BOTTLE (72603-490-01) | Fluoxetine | NorthStar Rx LLC | 2025-09-01 |
| 72603-0490-02 | 500 CAPSULE in 1 BOTTLE (72603-490-02) | Fluoxetine | NorthStar Rx LLC | 2025-09-01 |
| 72603-0490-03 | 1000 CAPSULE in 1 BOTTLE (72603-490-03) | Fluoxetine | NorthStar Rx LLC | 2025-09-01 |
| 72789-0554-21 | 21 CAPSULE in 1 BOTTLE, PLASTIC (72789-554-21) | Fluoxetine | PD-Rx Pharmaceuticals, Inc. | 2026-05-05 |
| 72789-0554-30 | 30 CAPSULE in 1 BOTTLE, PLASTIC (72789-554-30) | Fluoxetine | PD-Rx Pharmaceuticals, Inc. | 2026-04-20 |
| 72789-0554-90 | 90 CAPSULE in 1 BOTTLE, PLASTIC (72789-554-90) | Fluoxetine | PD-Rx Pharmaceuticals, Inc. | 2026-03-10 |
| 77771-0113-01 | 100 CAPSULE in 1 BOTTLE (77771-113-01) | Fluoxetine | RADHA PHARMACEUTICALS, INC. | 2022-10-24 |
| 77771-0113-10 | 1000 CAPSULE in 1 BOTTLE (77771-113-10) | Fluoxetine | RADHA PHARMACEUTICALS, INC. | 2022-10-24 |
| 77771-0114-01 | 100 CAPSULE in 1 BOTTLE (77771-114-01) | Fluoxetine | RADHA PHARMACEUTICALS, INC. | 2022-10-24 |
| 77771-0114-10 | 1000 CAPSULE in 1 BOTTLE (77771-114-10) | Fluoxetine | RADHA PHARMACEUTICALS, INC. | 2022-10-24 |
| 77771-0115-01 | 100 CAPSULE in 1 BOTTLE (77771-115-01) | Fluoxetine | RADHA PHARMACEUTICALS, INC. | 2022-10-24 |
| 77771-0115-05 | 500 CAPSULE in 1 BOTTLE (77771-115-05) | Fluoxetine | RADHA PHARMACEUTICALS, INC. | 2022-10-24 |
| 82009-0100-10 | 1000 CAPSULE in 1 BOTTLE (82009-100-10) | Fluoxetine | QUALLENT PHARMACEUTICALS HEALTH LLC | 2023-09-01 |
| 82009-0101-10 | 1000 CAPSULE in 1 BOTTLE (82009-101-10) | Fluoxetine | QUALLENT PHARMACEUTICALS HEALTH LLC | 2023-09-01 |
| 82009-0102-05 | 500 CAPSULE in 1 BOTTLE (82009-102-05) | Fluoxetine | QUALLENT PHARMACEUTICALS HEALTH LLC | 2023-09-01 |
Observed labelers:
Bryant Ranch Prepack (38) ·
Proficient Rx LP (30) ·
Aurobindo Pharma Limited (20) ·
BluePoint Laboratories (14) ·
NorthStar Rx LLC (14) ·
A-S Medication Solutions (12)
· +27 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.